Publications
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) - 20182018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Internal medicine for bachelor and master degree students2017 | First Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL)2013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Conflict of Interest: The World Medical Association Statement2011 | Third Faculty of Medicine
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Risk factors in chronic lymphocytic leukemia, validation of flow cytometric detection using RT-PCR and immunohistochemistry2009 | Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...
